15:15 , Mar 30, 2018 |  BC Week In Review  |  Financial News

Adagene raises $50M in series C for antibodies in China

Adagene Inc. (Suzhou, China) raised $50 million in an oversubscribed series C round led by Sequoia China with participation from New World TMT, AVIC Trust, King Star Capital, Gopher Asset Management and other undisclosed investors....
20:04 , Mar 27, 2018 |  BC Extra  |  Financial News

Chinese antibody company Adagene raises $50M series C

Adagene Inc. (Suzhou, China) raised $50 million in an oversubscribed series C round led by Sequoia China with participation from New World TMT, AVIC Trust, King Star Capital, Gopher Asset Management and other undisclosed investors....
18:33 , Mar 23, 2018 |  BC Week In Review  |  Company News

WuXi to supply manufacturing for Adagene's clinical trials

WuXi Biologics Inc. (HKSE:2269) will support manufacturing of products from Adagene Inc. (Suzhou, China) for use in Chinese and U.S. clinical trials. Adagene is using its Dynamic Precision Library (DPL) technology to generate and develop...
19:47 , Sep 8, 2017 |  BC Week In Review  |  Financial News

Eight Roads launches $250M China Healthcare Fund

Eight Roads (London, U.K.) launched its $250 million China Healthcare Fund. The fund will invest in healthcare services, IT and digital health, medical technology and therapeutics, which will comprise 40% of the allocated funding. It...
21:12 , Sep 6, 2017 |  BC Extra  |  Financial News

Eight Roads launches $250M China Healthcare Fund

Eight Roads launched its $250 million China Healthcare Fund. The fund will invest in healthcare services, IT and digital health, medical technology and therapeutics, which will comprise 40% of the allocated funding. It is the...
08:00 , Feb 1, 2016 |  BC Week In Review  |  Financial News

Adagene completes venture financing

Adagene Inc. , Suzhou, China   Business: Antibodies   Date completed: 2016-01-28   Type: Venture financing   Raised: $28 million   Investors: GP Capital; New World TMT; Eight Roads Ventures China; F-Prime Capital; WuXi Corporate...
02:29 , Jan 29, 2016 |  BC Extra  |  Financial News

Chinese antibody play Adagene raises $28M

Adagene Inc. (Suzhou, China) raised $28 million in a series B round led by new investor GP Healthcare Capital. Also participating were new investor New World TMT and existing investors Eight Roads Ventures China (formerly...
08:00 , Dec 15, 2014 |  BC Week In Review  |  Financial News

Adagene completes venture financing

Adagene Inc. , Suzhou, China   Business: Antibodies   Date completed: 2014-12-08   Type: Venture financing   Raised: $8 million   Investors: Fidelity Biosciences; Fidelity Growth Partners Asia; WuXi Corporate Venture Fund  ...
02:59 , Dec 10, 2014 |  BC Extra  |  Financial News

China's Adagene raises $8M in series A

Adagene Inc. (Suzhou, China) raised $8 million in series A funding from Fidelity Biosciences; Fidelity Growth Partners Asia; and WuXi Venture Fund, the investment arm of Chinese CRO WuXi PharmaTech Inc. (NYSE:WX). Adagene uses its...
07:00 , Jun 28, 1993 |  BioCentury  |  Strategy

Adagene finds $3M angel

Adagene Inc., which is developing consumer market applications for recombinant lactoferrin, was to announce this week that it has completed a $3 million first round financing from a single private investor, Gordon Cain, of Houston....